Biosensis MAP2 antibodies

Friday, 05 April, 2024 | Supplied by: Sapphire Bioscience


Microtuble-associated protein 2 (MAP2) is a protein that plays a crucial role in the regulation of microtubule dynamics and interactions, essential in neurogenesis. Biosensis’s validated MAP2 antibodies are designed to help users identify MAP2, whether they are detecting MAP2a, MAP2b or the distinctive MAP2c variant.

The company’s antibodies for MAP2 variants include antibodies that specifically target MAP2a and MAP2b, demonstrating high performance in western blots, as well as antibodies that identify all four MAP2 variants. They are distributed in Australia and New Zealand by Sapphire Bioscience.

Online: www.sapphirebioscience.com
Phone: 02 9698 2022
Related Products

AlphaThera oYo-Link Antibody Labeling Reagents

AlphaThera's oYo-Link Antibody Labeling Reagents enable site-specific antibody labelling....

Bio-Rad Laboratories StarBright Red 715, 775 and 815 Dyes and expanded antibody markers

The StarBright Dyes — proprietary fluorescent nanoparticles conjugated to flow-validated...

RevMAb Biosciences histone family protein monoclonal antibodies

RevMAb Biosciences offers a wide range of recombinant monoclonal antibodies against histone...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd